Vanshika Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.94 Cr
as on 16-12-2024
- Revenue 441.14%
(FY 2023)
- Profit 329.95%
(FY 2023)
- Ebitda 388.35%
(FY 2023)
- Net Worth -16.80%
(FY 2023)
- Total Assets 81.37%
(FY 2023)
About Vanshika Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹6.94 Cr.
Rathnakar Vemulapalli, Vemulapalli Jaswanth, Puram Nikhilesh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2021PTC151036
- Company No.
151036
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vanshika Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rathnakar Vemulapalli  | Director | 21-Jun-2021 | Current |
| Vemulapalli Jaswanth | Director | 21-Jun-2021 | Current |
| Puram Nikhilesh | Director | 18-Jun-2024 | Current |
| Santhi Gangapalli | Director | 29-Apr-2021 | Current |
| Ravi Gangapalli | Director | 02-May-2022 | Current |
Financial Performance of Vanshika Laboratories.
Vanshika Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 441.14% increase. The company also saw a substantial improvement in profitability, with a 329.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanshika Laboratories?
Unlock access to Vanshika Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gensynth Laboratories Private LimitedActive 20 years 2 daysSanthi Gangapalli and Ravi Gangapalli are mutual person
Surabhi Industries (India) Private LimitedActive 10 years 5 monthsRavi Gangapalli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Oct 2021 | ₹6.94 Cr | Open |
How Many Employees Work at Vanshika Laboratories?
Vanshika Laboratories has a workforce of 13 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanshika Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanshika Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
